Thursday, 30 May 2013

GSK bets on chimp virus with $321 million vaccines buy

By Ben Hirschler LONDON, May 29 (Reuters) - GlaxoSmithKline is betting on a new vaccine technology based on chimpanzee viruses by acquiring Swiss-based Okairos for 250 million euros ($321 million) - the latest bolt-on biotech buy by a big drugmake...

Source: http://health.yahoo.net/news/s/nm/gsk-bets-on-chimp-virus-with-321-million-vaccines-buy

explained here as explained here resource source

Posted by at

No comments:

Post a Comment

Note: only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)